1-5 of 5
David Dornan, Ph.D
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

FC-Gamma Receptor (FCGR) 2A and 3A Polymorphisms Do Not Influence the Outcome of Relapsed or Refractory CLL Patients Treated with Rituximab, Fludarabine, and Cyclophosphamide (R-FC) or Fludarabine, and Cyclophosphamide (FC) Alone.

David Dornan, Ph.D, Olivia Spleiss, Ph.D, Ru-Fang T Yeh, PhD, Guillemette Duchateau-Nguyen, PhD, Tadeusz Robak, Sergey I Moiseev, MD, Anna Dmoszynska, MD, Philippe Solal-Celigny, MD, Krzysztof Warzocha, MD, PhD, Javier Loscertales, MD, John Catalano, MD, Boris V Afanasiev, MD, Loree Larratt, MD, Viktor A Rossiev, MD, PhD, Isabelle Bence-Bruckler, MD, FRCPC, Christian H. Geisler, MD, DMSc, Marco Montillo, MD, Michael K. Wenger, MD, Martin Weisser, MD
Journal: Blood
Blood (2009) 114 (22): 2338.
https://doi.org/10.1182/blood.V114.22.2338.2338
Published: 2009
Journal Articles

CD40 Pathway Activation Status Predicts Response to CD40 Targeted Therapy in Diffuse Large b-Cell Lymphoma.

David Dornan, Ph.D, Bart Burington, Ph.D, Peng Yue, Ph.D, Xiaoyan Shi, Ph.D, Ranjana Advani, MD, Nancy Yu, Jeffrey T Lau, Shang-Fan Yu, Sven De Vos, MD, PhD, Stephen M Ansell, Andres Forero-Torres, MD, Zora Modrusan, Hartmut Koeppen, Teddy Yang, Changchun Du, BM, BS, Kristi Elkins, Andrew G. Polson, Rienk Offringa, Nancy Whiting, PharmD, BCOP, Allen J. Ebens, PhD
Journal: Blood
Blood (2009) 114 (22): 2721.
https://doi.org/10.1182/blood.V114.22.2721.2721
Published: 2009
Journal Articles

PI3K Signaling Pathway Activation Predicts Class I PI3K Inhibitor GDC-0941 Sensitivity in AML.

Xiaoju Max Ma, PhD, Changchun Du, BM, BS, Laura Sun, Xiaoyan Shi, Ph.D, Lori Friedman, David Dornan, Ph.D, Allen J. Ebens, PhD
Journal: Blood
Blood (2009) 114 (22): 1057.
https://doi.org/10.1182/blood.V114.22.1057.1057
Published: 2009
Journal Articles

Fc Gamma Receptor 3a Genotype Predicts Overall Survival for Follicular Lymphoma Patients Treated On Southwest Oncology Group Trials with Combined Monoclonal Antibody Plus Chemotherapy but Not Chemotherapy Alone.

Daniel O. Persky, MD, David Dornan, Ph.D, Bryan H Goldman, MS, Rita M. Braziel, MD, Richard I Fisher, MD, Michael LeBlanc, PhD, David G. Maloney, MD, PhD, Thomas P. Miller, MD, Oliver W. Press, MD, PhD, Lisa M. Rimsza, MD
Journal: Blood
Blood (2009) 114 (22): 111.
https://doi.org/10.1182/blood.V114.22.111.111
Published: 2009
Journal Articles

Identification of a Diagnostic Gene Signature for SGN-40, Anti-CD40 Monoclonal Antibody, in Pre-Clinical NHL Models and the Role of FAS in SGN-40 Mediated Apoptosis.

Xiaoyan Shi, Ph.D, Bart Burington, Ph.D, Tom Januario, Jeffrey T Lau, Shang-Fan Yu, Allen Ebens, Ph.D, David Dornan, Ph.D
Journal: Blood
Blood (2008) 112 (11): 1593.
https://doi.org/10.1182/blood.V112.11.1593.1593
Published: 2008